Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Mounjaro Stomach Paralysis Risks Higher Than Other Diabetes Drugs, Review Finds The study also linked diabetes drugs like Invokana, Farxiga and Jardiance to more than three times the risk of genital infections, as well as ketoacidosis and limb amputation risks. August 26, 2025 Irvin Jackson Add Your Comments As hundreds of individuals move forward with gastroparesis lawsuits against the makers of Mounjaro, Ozempic and similar diabetes drugs, a new study highlights the extent of risks these drugs pose, indicating that Mounjaro may pose the greatest risk of stomach paralysis. Chinese researchers published the findings in The BMJ on August 14, after looking at a variety of medications used to treat type 2 diabetes, and linking some of the most serious gastrointestinal issues to a popular new class of drugs, known as glucagon-like peptide-1 (GLP-1) receptor agonists, which include Mounjaro, Ozempic, Trulicity and others. While the drugs were originally developed to treat type 2 diabetes, use of the treatments has exploded in popularity over the past few years due to their weight loss benefits. However, over the past few years, a rapidly growing number of users have been filing Mounjaro lawsuits, Ozempic lawsuits and Wegovy lawsuits against the drug makers, alleging that they withheld critical safety information and warnings, particularly about the risk that users may be left with devastating stomach paralysis injuries. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION In this new study, researchers conducted a clinical review of multiple classes of diabetes drugs, including GLP-1 medications, sodium-glucose cotransporter-2 (SGLT-2) inhibitors and other types of diabetes drugs’ effects on heart disease and kidney disease. They looked at data on 493,168 patients from 869 clinical trials, finding that all of the drugs have well-established heart and kidney benefits. However, GLP-1 medications, which did provide significant weight loss benefits, were linked to four times the risk of gastrointestinal side effects compared to other types of diabetes drugs. The drug Mounjaro (tirzepatide), specifically, carried the highest weight loss benefits and the highest stomach paralysis risks, the researchers noted. The data also linked SGLT-2 inhibitors, like Invokana, Farxiga and Jardiance, to more than triple the relative risk of genital infections, ketoacidosis and increased amputation risks. Researchers say the study is a “living” review that will be updated on a regular basis and can be used to guide specific care of individual diabetes patients’ needs. As more clinical trial data is accrued on the drugs, it will be added to the database and the risks recalculated. The research team indicates the goal is to quickly translate evidence for the benefits and side effects of diabetes drugs to quickly inform policy and practice. Mounjaro, Ozempic Stomach Paralysis Lawsuits Novo Nordisk and Eli Lilly face more than 2,400 product liability lawsuits brought throughout the federal court system over the past few years, each indicating that the manufacturers failed to provide adequate warning that the diabetes and weight loss drugs could cause severe gastrointestinal problems, including gastroparesis, bowel obstructions and other painful side effects. Given the common questions of fact and law raised nationwide, all Ozempic gastroparesis lawsuits have been centralized in a multidistrict litigation (MDL) in the Eastern District of Pennsylvania, where U.S. District Judge Karen Marston is overseeing coordinated discovery and pretrial proceedings. As part of that process, the court will eventually select a small group of representative cases to serve as early “bellwethers,” providing insight into how juries may respond to recurring evidence and testimony. Before moving to that stage, Judge Marston directed both sides to resolve several “cross-cutting” issues with broad implications for the litigation. Once those matters are addressed, the MDL is expected to proceed with preparing the first set of cases for jury consideration. While the verdicts will not directly determine the outcome of other GLP-1 claims, they are likely to shape settlement negotiations, particularly for related Mounjaro gastroparesis lawsuits. If no resolution is reached after these bellwethers, the remaining lawsuits will be sent back to their original courts for individual trial dates. Find Out If You Qualify for Ozempic or Wegovy Compensation Tags: Diabetes, Farxiga, Gastroparesis, Heart Disease, Jardiance, Ketoacidosis, Kidney Disease, Mounjaro, Ozempic, Stomach Paralysis, Wegovy, Weight Loss Image Credit: MKPhoto12 / Shutterstock.com Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Ozempic, Wegovy and Mounjaro Stories Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues October 28, 2025 Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges October 21, 2025 Ozempic, Wegovy Kidney Side Effects Highlighted in New Study October 10, 2025 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Studies Highlight How Sports Betting Apps Cause Compulsive Gambling Addiction (Posted: today) Researchers warn that sports-betting apps use reward-based design and constant engagement tactics that can fuel addiction among young adults—sparking a surge of lawsuits accusing major platforms of exploiting these vulnerabilities for profit. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITGambling Addiction Treatment Needs Surge Amid Sports Betting App Promotions (10/22/2025)Gambling Livestreams May Be Harming Young Adults: Study (10/16/2025)DraftKings Faces Lawsuit Over Failure To Design Sports Betting Website for Gamblers Disabilities (09/29/2025) Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (Posted: yesterday) Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Four BioZorb Breast Marker Lawsuits Set for Trial Between Jan. and April 2026 (Posted: 4 days ago) A federal judge has set key scheduling deadlines for the four first bellwether trials over claims that BioZorb breast markers are defectively designed. MORE ABOUT: BIOZORB LAWSUITLawyers in BioZorb Implant Lawsuits Request Updated Deadlines in Pretrial Schedule (10/15/2025)Tamoxifen Side Effects Linked to Uterine Tumors in Breast Cancer Patients: Study (09/16/2025)Five Women File Joint Lawsuit Over BioZorb Breast Implant Side Effects (09/09/2025)
Studies Highlight How Sports Betting Apps Cause Compulsive Gambling Addiction (Posted: today) Researchers warn that sports-betting apps use reward-based design and constant engagement tactics that can fuel addiction among young adults—sparking a surge of lawsuits accusing major platforms of exploiting these vulnerabilities for profit. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITGambling Addiction Treatment Needs Surge Amid Sports Betting App Promotions (10/22/2025)Gambling Livestreams May Be Harming Young Adults: Study (10/16/2025)DraftKings Faces Lawsuit Over Failure To Design Sports Betting Website for Gamblers Disabilities (09/29/2025)
Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (Posted: yesterday) Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Four BioZorb Breast Marker Lawsuits Set for Trial Between Jan. and April 2026 (Posted: 4 days ago) A federal judge has set key scheduling deadlines for the four first bellwether trials over claims that BioZorb breast markers are defectively designed. MORE ABOUT: BIOZORB LAWSUITLawyers in BioZorb Implant Lawsuits Request Updated Deadlines in Pretrial Schedule (10/15/2025)Tamoxifen Side Effects Linked to Uterine Tumors in Breast Cancer Patients: Study (09/16/2025)Five Women File Joint Lawsuit Over BioZorb Breast Implant Side Effects (09/09/2025)